Similar to the PT and D‐dimer levels, inflammatory markers were nonspecifically elevated in both groups; although serum ferritin levels in COVID‐19 cases were high, the increment was of lower magnitude than in other ill cancer patients. Here, F2 is linked to COVID-19.